MedPath

Chiba University

Chiba University logo
πŸ‡―πŸ‡΅Japan
Ownership
Private
Established
1949-01-01
Employees
-
Market Cap
-
Website
http://www.chiba-u.ac.jp

Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

Phase 4
Recruiting
Conditions
ANCA Associated Vasculitis (AAV)
Interventions
Drug: Avacopan, prednisolone and rituximab
First Posted Date
2024-09-25
Last Posted Date
2025-05-04
Lead Sponsor
Chiba University
Target Recruit Count
160
Registration Number
NCT06611696
Locations
πŸ‡―πŸ‡΅

Dokkyo Medical University, Mibu, Tochigi, Japan

πŸ‡―πŸ‡΅

Juntendo Univeristy, Bunkyoku, Tokyo, Japan

πŸ‡―πŸ‡΅

Fujita Health University Hospital, Toyoake, Aichi, Japan

and more 19 locations

Open-label Clinical Trial of Lacosamide in ALS

Phase 1
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
First Posted Date
2017-06-14
Last Posted Date
2020-07-15
Lead Sponsor
Chiba University
Target Recruit Count
7
Registration Number
NCT03186040
Locations
πŸ‡―πŸ‡΅

Chiba University Hospital, Chiba, Japan

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis

Phase 4
Completed
Conditions
Arthritis, Rheumatoid
Interventions
First Posted Date
2016-05-12
Last Posted Date
2021-01-20
Lead Sponsor
Chiba University
Target Recruit Count
211
Registration Number
NCT02770794
Locations
πŸ‡―πŸ‡΅

Chiba University Hospital, Chiba, Japan

JET-GBS - Japanese Eculizumab Trial for GBS

Phase 2
Completed
Conditions
Gullain Barre Syndrome
Interventions
Drug: Placebo
First Posted Date
2015-07-09
Last Posted Date
2017-10-11
Lead Sponsor
Chiba University
Target Recruit Count
34
Registration Number
NCT02493725
Locations
πŸ‡―πŸ‡΅

Nagoya University Hospital, Nagoya, Aichi, Japan

πŸ‡―πŸ‡΅

Hokkaido University Hospital, Sapporo, Hokkaido, Japan

πŸ‡―πŸ‡΅

Dokkyo Medical University Hospital, Mibu, Tochigi, Japan

and more 10 locations

Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial

Phase 1
Completed
Conditions
Attention Deficit Disorder With Hyperactivity Disease
Attention Deficit and Disruptive Behavior Disorders
Hyperkinesis
Interventions
First Posted Date
2014-12-02
Last Posted Date
2019-03-19
Lead Sponsor
Chiba University
Target Recruit Count
21
Registration Number
NCT02305134
Locations
πŸ‡―πŸ‡΅

Department of Psychiatry, Chiba University School of Medicine, Chiba, Chuo-ku, Japan

Low-dose Glucocorticoid Vasculitis Induction Study

Phase 4
Conditions
Wegener Granulomatosis
Microscopic Polyangiitis
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions
Drug: Glucocorticoids
First Posted Date
2014-07-23
Last Posted Date
2021-01-27
Lead Sponsor
Chiba University
Target Recruit Count
140
Registration Number
NCT02198248
Locations
πŸ‡―πŸ‡΅

Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan

πŸ‡―πŸ‡΅

Saitama Medical Center, Kawagoe, Saitama, Japan

πŸ‡―πŸ‡΅

Dokkyo Medical University, Mibu, Tochigi, Japan

and more 14 locations

Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

Phase 2
Completed
Conditions
POEMS Syndrome
Interventions
Drug: Lenalidomide+Dexamethasone
First Posted Date
2014-07-18
Last Posted Date
2016-07-29
Lead Sponsor
Chiba University
Target Recruit Count
5
Registration Number
NCT02193698
Locations
πŸ‡―πŸ‡΅

Chiba University Graduate School of Medicine Department of neurology, Chiba, Japan

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

Phase 4
Conditions
Pancreatic Tumor
Bile Duct Tumor
Interventions
Dietary Supplement: Oral IMPACT
First Posted Date
2013-10-25
Last Posted Date
2013-10-25
Lead Sponsor
Chiba University
Target Recruit Count
60
Registration Number
NCT01969110
Locations
πŸ‡―πŸ‡΅

Chiba University Hospital, Chiba, Japan

Ifenprodil Tartrate Treatment of Adolescents With Post-traumatic Stress Disorder: a Double-blind, Placebo-controlled Trial

Phase 1
Completed
Conditions
Posttraumatic Stress Disorders
Interventions
First Posted Date
2013-07-11
Last Posted Date
2019-03-19
Lead Sponsor
Chiba University
Target Recruit Count
10
Registration Number
NCT01896388
Locations
πŸ‡―πŸ‡΅

Department of Psychiatry, Chiba University School of Medicine Chiba, Chuo-ku, Japan 260-8670, Chiba, Chuo-ku, Japan

An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression

Phase 2
Completed
Conditions
Depression
Adolescent
Interventions
First Posted Date
2013-04-19
Last Posted Date
2014-05-23
Lead Sponsor
Chiba University
Target Recruit Count
10
Registration Number
NCT01835847
Locations
πŸ‡―πŸ‡΅

Department of Psychiatry, Chiba University School of Medicine, Chiba, Chuo-ku, Japan

Β© Copyright 2025. All Rights Reserved by MedPath